Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor/Glucophage XR
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate safety and pharmacokinetic properties of the two
treatments, the administration of CJ-30056 and the co-administration of atorvastatin and
metformin XR, in healthy volunteers.